ClinicalTrials.gov
ClinicalTrials.gov Menu

Study of 4-Demethyl-4-cholesteryloxycarbonylpenclome in Patients With Brain Tumors (DM-CHOC-PEN)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02038218
Recruitment Status : Completed
First Posted : January 16, 2014
Last Update Posted : June 23, 2016
Sponsor:
Collaborators:
Tulane University Medical Center, New Orleans, LA
Icahn School of Medicine at Mount Sinai
Detroit Clinical Research Center, Farmington Hills, Lansing and Owasso, MI
National Cancer Institute (NCI)
Ochsner Health System
The University of Texas Health Science Center, Houston
Information provided by (Responsible Party):
DEKK-TEC, Inc.

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : May 2016
  Actual Study Completion Date : June 2016